Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Journal of Urology|September 1, 1985
Experimental observations on dissolution of uric acid calculiM V Sadi, N Saltzman, G Feria, et al.The Journal of Supportive Oncology|March 19, 2010
The effects of integrating an advanced practice palliative care nurse in a community oncology center: a pilot studyMaryjo Prince-Paul, Christopher J Burant, Joel N Saltzman, et al.Cancer Medicine|June 1, 2021
Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014Aman Opneja, Gino Cioffi, Asrar Alahmadi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Phase II randomized trial of carboplatin, paclitaxel, bevacizumab with or without cixutumumab (IMC-A12) in patients with advanced non-squamous, non-small-cell lung cancer: a trial of the ECOG-ACRIN Cancer Research Group (E3508)A Argiris, J W Lee, J Stevenson, et al.Acta Haematologica|July 24, 2019
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903)Sanford Kempin, Zhuoxin Sun, Neil E Kay, et al.Frontiers in Oncology|March 11, 2022
Associations of Racial and Ethnic Category, Age, Comorbidities, and Socioeconomic Factors on Concordance to NCCN Guidelines for Patients With High-Risk Biliary Tract Cancers After SurgeryLauren F Huang, Augustine Hong, Gino Cioffi, et al.Gynecologic Oncology|December 29, 2016
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group studyCarolyn K McCourt, Wei Deng, Don S Dizon, et al.Cancer|December 7, 2017
Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)Neal J Meropol, Yang Feng, Jean L Grem, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2019
Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer: ECOG-ACRIN 5508Suresh S Ramalingam, Suzanne E Dahlberg, Chandra P Belani, et al.Pageof 1